Détails
Marque
Collection
n.c
Parution
2021-05-10
Pages
151 pages
EAN papier
9783030725983
Langue
Anglais
Informations ebook
EAN PDF
9783030725990
Prix
73,84 €
En savoir plus
Nb pages copiables 1
Nb pages imprimables 15
Taille du fichier 5018 Ko
EAN EPUB
9783030725990
Prix
73,84 €
En savoir plus
Nb pages copiables 1
Nb pages imprimables 15
Taille du fichier 3983 Ko
Compatibilité

mobile-and-tablet Pour vérifier la compatibilité avec vos appareils,
consultez la page d'aide

Auteur(s) du livre


Melvyn Little received his degree in chemistry and PhD in biochemistry from Bangor University, Wales and subsequently completed a Postdoc at the Max-Planck-Institute for Cell Biology in Wilhelmshaven, Germany. He has served as head of the Research Group “Recombinant Antibodies” at the German Cancer Research Center in Heidelberg and as an External Professor of Biochemistry at Heidelberg University.

In addition, he was a Co-founder and Supervisory Board Member of the biotech firm Affitech in Oslo, Norway, as well as Founder and Management Board Member of the biotech firm Affimed in Heidelberg.

His primary research interest is in the development of dual binding antibodies for recruiting killer immune cells to destroy tumor cells. Currently he is in retirement and a biotechnology consultant.

Avis clients

Suggestions personnalisées

Restez informé(e) des événements et promotions ebook

Paiements sécurisés

Paiements sécurisés